Open Label, Healthy Volunteers, Bioequivalence Study With Naloxegol

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

Opioid Induced Constipation

Interventions

DRUG

Naloxegol

Naloxol IR tablet 25 mg (naloxegol oxalate) commercial formulation

DRUG

Naloxegol

Naloxegol film-coated Phase III formulation 25 mg film-coated IR tablet

Trial Locations (1)

Research Site, London